esbriet
roche registration gmbh - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunosuppressants - esbriet is indicated in adults for the treatment of idiopathic pulmonary fibrosis.
esbriet 801mg tablets
roche products ltd - pirfenidone - tablet - 801mg
esbriet 267mg tablets
roche products ltd - pirfenidone - tablet - 267mg
esbriet 267 mg
roche pharmaceuticals (israel) ltd - pirfenidone - hard capsule - pirfenidone 267 mg - pirfenidone - esbriet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).27/01/2019 בקשה לתוספת התויה renal impairment no dose adjustment is necessary in patients with mild to moderate renal impairment. esbriet should be used with caution in patients with moderate (crcl 30-50 ml/min) renal impairment.
esbriet 267 mg
roche pharmaceuticals (israel) ltd - pirfenidone - hard capsule - pirfenidone 267 mg - pirfenidone - esbriet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).27/01/2019 בקשה לתוספת התויה renal impairment no dose adjustment is necessary in patients with mild to moderate renal impairment. esbriet should be used with caution in patients with moderate (crcl 30-50 ml/min) renal impairment.
esbriet 267 mg tablets
roche pharmaceuticals (israel) ltd - pirfenidone - film coated tablets - pirfenidone 267 mg - pirfenidone - esbriet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).
esbriet 801 mg tablets
roche pharmaceuticals (israel) ltd - pirfenidone - film coated tablets - pirfenidone 801 mg - pirfenidone - esbriet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf)..
pirfenidone 267mg tablets
celix pharma ltd - pirfenidone - tablet - 267mg
pirfenidone 801mg tablets
celix pharma ltd - pirfenidone - tablet - 801mg
pirfenidone clonmel 267 mg film-coated tablets
clonmel healthcare ltd - pirfenidone - film-coated tablet - pirfenidone